LUPUS 2025, the 16th International Congress on SLE
Following is the complete guide to Aurinia’s accepted abstracts at LUPUS 2025:
Title: Achievement of Proteinuria Less Than 0.4 G/G in the Phase 3 AURORA 1 Study of Voclosporin in Lupus Nephritis
Authors: Maria Dall'Era, Brad Rovin, Salem Almaani, Lily Cipolla, Vanessa Birardi, Ernie Yap
Date: Thursday, May 22
Time: 2:20 PM ET
Abstract Number: 232
Title: Baseline Demographics, Clinical Characteristics, and Treatment Regimens of an Initial Cohort of Patients Receiving Voclosporin for Lupus Nephritis in the Enlight-LN Registry
Authors: Laura Geraldino-Pardilla, Leanna Wise, Mohammad Kamgar, Niloofar Nobakht, Lily Cipolla, Lucy Hodge, Keelin Da'Lee
Poster Session: Lupus Nephritis-Clinical
Date/Time: On display for duration of meeting
Abstract Number: 249
Title: Attainment of Ultra-Low Levels of UPCR in the AURORA 1 Study Associated with Alterations in the Circulating Lipidome
Authors: Farsad Afshinnia, Subramaniam Pennathur, Michelle Zubrycki, Linda Rehaume, Lucy Hodge
Date: Thursday, May 22
Time: 12:10 – 1:10 PM ET
Abstract Number: 252
